Ex-Legend CEO takes helm at biotech startup scouring the globe for drugs

Legend Biotech shares increased by 5% following Q2 earnings and revenue results that exceeded market estimates. The company's financial performance was detailed during the Legend Biotech Q2 Earnings Call Highlights. Simultaneously, the former CEO of Legend Biotech has transitioned to a new role, taking the helm at a biotech startup. This new venture focuses on scouring the globe to identify and develop new drugs, marking a significant leadership shift within the broader biotechnology sector.